Literature DB >> 8083650

Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine.

D C Powers1.   

Abstract

We previously reported an age-associated impairment of serum immunoglobulin G (IgG) antibody responses to inactivated influenza virus vaccine. The present study extends these observations by examining the IgG subclass distribution of vaccine responses measured by enzyme linked immunosorbent assay in healthy adults aged < 40 (young), 40-64 (middle-aged), and > or = 65 (elderly) years. Serological responses in all age groups showed antibodies that were predominantly IgG1 and secondarily IgG3. Influenza antigen-specific IgG4 titers did not change following vaccination, and antibodies of the IgG2 subclass were not detected in any serum specimens. Aging was associated with a significant impairment of IgG1, but not of IgG3, antibody production. Relative differences in the magnitude and frequency of response between IgG1 and IgG3 subclasses, which were present in young and middle-aged adults (viz., IgG1 > IgG3), were less apparent in the elderly. This observation was confirmed in a second analysis of IgG subclass-specific responses in a separate cohort of elderly vaccinees. These results suggest that the age-related impairment of humoral responses to inactivated influenza virus vaccine is primarily accounted for by differences in IgG1 antibody production, and that IgG3 antibodies make up a larger proportion of the overall serologic response in the elderly than they do in younger persons.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083650     DOI: 10.1002/jmv.1890430111

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

2.  Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

Authors:  D C Powers; E D Kilbourne; B E Johansson
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

3.  Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine.

Authors:  Wilbur H Chen; Alan S Cross; Robert Edelman; Marcelo B Sztein; William C Blackwelder; Marcela F Pasetti
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

Review 4.  Use of licensed vaccines for active immunization of the immunocompromised host.

Authors:  L A Pirofski; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

6.  Effects of adjuvants on IgG subclasses elicited by virus-like particles.

Authors:  Maria Luisa Visciano; Maria Tagliamonte; Maria Lina Tornesello; Franco M Buonaguro; Luigi Buonaguro
Journal:  J Transl Med       Date:  2012-01-05       Impact factor: 5.531

7.  Age-Related Changes in Human Peripheral Blood IGH Repertoire Following Vaccination.

Authors:  Yu-Chang Bryan Wu; David Kipling; Deborah K Dunn-Walters
Journal:  Front Immunol       Date:  2012-07-09       Impact factor: 7.561

8.  Age-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 and CD8 T cell immunity.

Authors:  Aishwarya Sridharan; Marc Esposo; Khushboo Kaushal; Jia Tay; Kathyrn Osann; Sudhanshu Agrawal; Sudhir Gupta; Anshu Agrawal
Journal:  Age (Dordr)       Date:  2010-10-16

9.  Physical activity and influenza-coded outpatient visits, a population-based cohort study.

Authors:  Eric Siu; Michael A Campitelli; Jeffrey C Kwong
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

10.  Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011-2012 influenza vaccine season.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Nicholas V Mendez; Ana Marie Landin; Bonnie B Blomberg
Journal:  Immun Ageing       Date:  2013-04-22       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.